Pathophysiology, Diagnosis, and Management of Coronary Artery Aneurysms: A Review

Rengin Çetin Güvenç1, Abdullah Ayar Al Arfaj1, Hola Razouk1

  • 1Department of Cardiology, Okan University School of Medicine, 34959 Istanbul, Turkey.

PubMed

Insights

Coronary artery aneurysms (CAAs) are common findings in cardiac imaging. This review covers CAA causes, risks like thrombus formation and rupture, and management options from medical therapy to surgical intervention.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Coronary artery aneurysms (CAAs) are identified in up to 8% of patients undergoing coronary imaging.
  • Atherosclerosis-induced positive remodeling is the primary cause, though congenital, inflammatory, and traumatic factors also contribute.
  • CAAs pose risks including thrombus formation and distal embolization, with rupture being a rare but severe complication.

Purpose of the Study:

  • To provide a comprehensive overview of coronary artery aneurysms.
  • To detail nomenclature, classification, pathophysiology, and diagnostic approaches.
  • To emphasize current and emerging treatment strategies for managing CAA-related risks.

Main Methods:

  • Review of existing literature on coronary artery aneurysms.
  • Synthesis of data regarding etiology, clinical presentation, and complications.
  • Analysis of current management paradigms, including medical, percutaneous, and surgical interventions.

Main Results:

  • CAAs are frequently associated with atherosclerotic disease.
  • Thrombus formation and embolization are significant complications.
  • Management strategies are tailored based on aneurysm characteristics and patient risk factors.

Conclusions:

  • Coronary artery aneurysms require careful evaluation and management.
  • Percutaneous exclusion is suitable for aneurysms at risk of rupture or thrombosis.
  • Surgical correction is reserved for complex cases or when percutaneous options are unsuitable.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
257
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
241
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
308
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
401